Figure 2.

Schematic of SWOG SO500. A randomized phase III trial to test the strategy of changing therapy vs maintaining therapy for Metastatic Breast Cancer patients who have elevated circulating tumor cell levels at first follow-up assessment.

Swaby and Cristofanilli BMC Medicine 2011 9:43   doi:10.1186/1741-7015-9-43
Download authors' original image